Methyl 1-ethyl-4-nitro-1H-pyrazole-5-carboxylate, 95.0%, 5g

4-(5-Formyl-furan-2-yl)-benzonitrile, 1g

3-Hydroxydihydrofuran-2(3H)-one>98.0%(GC)25g

Benzyl 3,8-diazabicyclo[3.2.1]octane-3-carboxylate, 98%, 100mg

5-Amino-2-(4-methyl-piperazin-1-yl)-benzoic acid, 95.0%, 250mg

2H-3-Benzazepin-2-one, 3-[3-[[[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl]methylamino]propyl]-1,3,4,5-tetrahydro-7,8-dimethoxy-, hydrochloride (1:1), 99%, 5g

N-Butanesulfinic acid sodium salt, 100mg

4,5-DIHYDRO-1H-IMIDAZOLE-2-SULFONIC ACID, 98.0%, 100mg

(6-Bromo-pyridazin-3-yl)-dimethyl-amine, 98.0%, 250mg

2-(2,5-Dichlorothiophen-3-yl)acetic acid, 500mg

1-(3-Methoxypropyl)piperidin-4-amine, 95.0%, 5g

3'-AMINO-2',3'-DIDEOXYADENOSINE, 95.0%, 1g

Dipropylene glycol monobutyl ether, min 98%, for synthesis, 2.5 l, plastic packaging.